Novartis reported CHF62.92B in Equity Capital and Reserves for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Alcon AG ALC:SW 18.66B 826.3M
Amgen AMGN:US $ 2419M 1503M
Artemis Alpha ATS:LN 12.41B 3.51B
AstraZeneca AZN:LN 2951310.75M 184237.79M
Bayer BAYN:GR € 38019M 582M
Biogen BIIB:US $ 11872.5M 630.2M
Bristol Myers Squibb BMY:US $ 32600M 1020M
Eli Lilly And LLY:US $ 8544.7M 786.1M
Fresenius FRE:GR € 20664M 794M
Fresenius Medical Care FME:GR € 15451M 2216.5M
Galapagos GLPG:NA € 2646.9M 0.31M
Genmab GEN:DC DK 24482M 1763M
Gilead Sciences GILD:US $ 20215M 288M
GlaxoSmithKline GSK:LN 1637400M 19300M
Hikma Pharmaceutical HIK:LN 178.73B 2.59B
Lonza Group LONN:SW 10.01B 261M
Merck MRK:GR € 25955M 3036M
Novartis NOVN:VX SF 62925M 1385M
Novartis NVS:US $ 62925M 1385M
Orion ORNBV:FH € 749.9M 110M
Philips PHIA:NA € 14727M 265M
Recordati REC:IM € 1493.89M 44.45M
Regeneron Pharmaceuticals REGN:US $ 20687.8M 773.1M